FITC anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_FITC_1_110210
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_1_110210
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_2_110210
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
101205 50 µg 47 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101206 500 µg 132 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  2. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  3. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  4. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  5. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  6. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  7. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  8. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  9. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  10. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  11. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  12. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  13. Ostapoff K, et al. 2014. Cancer Res. 74:4966. PubMed
  14. Fan X, et al. 2015. Cancer Res. 75:86. PubMed
  15. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  16. Gupta P, Rajan M, Kulkarni S, et al. 2017. Int Immunopharmacol. 10.1016/j.intimp.2017.06.025. PubMed
  17. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  18. Bijland S, et al. 2019. F1000Res. 8:117. PubMed
  19. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  20. Miyatake Y, et al. 2018. J Immunol. 201:3051. PubMed
  21. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
  22. Song R, et al. 2022. Immunology. 165:274. PubMed
  23. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  24. He D, et al. 2022. Immunity. 55:159. PubMed
  25. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  26. Du Y, et al. 2022. FASEB J. 36:e22248. PubMed
  27. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  28. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  29. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  30. Usui-Ouchi A, et al. 2022. Glia. 70:1762. PubMed
  31. Ocaña-Guzman R, et al. 2022. Cells. 11: . PubMed
  32. Li J, et al. 2022. FASEB J. 36:e22400. PubMed
  33. Dong H, et al. 2022. Proc Natl Acad Sci U S A. 119:e2123247119. PubMed
  34. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  35. Komori R, et al. 2022. Int J Mol Sci. 23: . PubMed
  36. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  37. Shen Z, et al. 2022. EBioMedicine. 85:104285. PubMed
  38. Xuan FL, et al. 2022. Front Immunol. 13:1005067. PubMed
  39. Foo CX, et al. 2023. Eur Respir J. 61: . PubMed
  40. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  41. Shang T, et al. 2022. Front Pharmacol. 13:1054176. PubMed
  42. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  43. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  44. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  45. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  46. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  47. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  48. Chen L, et al. 2022. Cancer Immunol Immunother. :. PubMed
  49. Chan L, et al. 2022. Cells. 12: . PubMed
  50. Wang L, et al. 2022. Nutrients. 15: . PubMed
  51. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  52. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  53. Li Y, et al. 2023. Cell Death Dis. 14:28. PubMed
  54. Freitag K, et al. 2023. Commun Biol. 6:40. PubMed
  55. Schmidt AD, et al. 2023. J Invest Dermatol. :. PubMed
  56. Jiang X, et al. 2023. Cell Discov. 9:7. PubMed
  57. Li B, et al. 2023. Nat Commun. 14:489. PubMed
  58. Schick J, et al. 2023. Elife. 12: . PubMed
  59. Zhu X, et al. 2023. Front Immunol. 14:1114802. PubMed
  60. Zhong CS, et al. 2022. Acta Pharmacol Sin. 43:1324. PubMed
  61. Mecklenburg J, et al. 2022. Brain Behav Immun. 101:246. PubMed
  62. Murotomi K, et al. 2022. Exp Biol Med (Maywood). 247:848. PubMed
  63. Zhao X, et al. 2022. Cell Mol Immunol. 19:540. PubMed
  64. Xin DQ, et al. 2022. Neural Regen Res. 17:2238. PubMed
  65. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  66. Tao X, et al. 2022. J Exp Med. 219:. PubMed
  67. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  68. Gaikwad H, et al. 2022. ACS Nano. . PubMed
  69. Rybova J, et al. 2022. J Inherit Metab Dis. 45:1175. PubMed
  70. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  71. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  72. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  73. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  74. Adzika GK, et al. 2023. Front Immunol. 14:1124649. PubMed
  75. Wang YC, et al. 2023. J Exp Med. 220:. PubMed
  76. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  77. Yang Y, et al. 2023. Cancers (Basel). 15:. PubMed
  78. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  79. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  80. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  81. Dona MSI, et al. 2023. Basic Res Cardiol. 118:11. PubMed
  82. Sun JY, et al. 2023. Sci Adv. 9:eade4110. PubMed
  83. Iguchi A, et al. 2023. iScience. 26:106375. PubMed
  84. Han S, et al. 2023. Int J Mol Sci. 24:. PubMed
  85. Zhu CL, et al. 2023. Int J Biol Sci. 19:1413. PubMed
  86. Thai LM, et al. 2023. iScience. 26:106477. PubMed
  87. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  88. Banka AL, et al. 2023. Nat Commun. 14:2462. PubMed
  89. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  90. Qin C, et al. 2023. iScience. 26:106588. PubMed
  91. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  92. Xu Y, et al. 2023. J Cancer. 14:1182. PubMed
  93. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
  94. Zhang Y, et al. 2023. NPJ Regen Med. 8:28. PubMed
  95. Chen SW, et al. 2023. Methods Mol Biol. 2683:53. PubMed
  96. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  97. Mawambo G, et al. 2023. J Neuroinflammation. 20:145. PubMed
  98. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  99. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  100. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  101. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  102. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  103. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  104. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  105. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  106. Gan C, et al. 2022. Respir Res. 23:32. PubMed
  107. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  108. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  109. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  110. Belmonte L, et al. 2016. Sci Rep. 6:35813. PubMed
  111. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  112. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  113. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  114. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  115. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  116. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  117. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  118. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
  119. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  120. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  121. Tu S, et al. 2020. Cellular Signalling. 73:109695. PubMed
  122. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  123. Tuominen S, et al. 2021. Eur J Nucl Med Mol Imaging. 48:1312. PubMed
  124. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  125. Poli V, et al. 2021. iScience. 24:103256. PubMed
  126. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  127. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  128. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  129. Zhu ZY, et al. 2022. Front Immunol. 12:781087. PubMed
  130. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  131. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  132. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  133. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  134. Chen S, et al. 2022. Cancer Discov. :. PubMed
  135. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  136. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  137. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  138. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  139. Wu G, et al. 2020. Front Oncol. 10:194. PubMed
  140. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  141. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  142. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  143. Kapadia D, et al. 2011. PLoS One. 6:e19376. PubMed
  144. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  145. Zhang YS, et al. 2018. Cancer Biol Ther. 19:735. PubMed
  146. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  147. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  148. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  149. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  150. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  151. Duan M, et al. 2022. Cell Commun Signal. 20:60. PubMed
  152. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  153. Li B, et al. 2022. iScience. 25:103772. PubMed
  154. DeMarco JK, et al. 2021. Vaccines (Basel). 9:. PubMed
  155. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  156. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  157. Tong X, et al. 2020. Front Pharmacol. 1.404166667. PubMed
  158. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  159. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  160. Lindborg JA et al. 2017. The Journal of Neuroscience. 37(43):10258-10277 . PubMed
  161. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  162. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  163. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  164. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  165. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  166. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  167. Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
  168. Kasper M, et al. 2021. Elife. 10:. PubMed
  169. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  170. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  171. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  172. Caiado F, et al. 2013. Cancer Res. 73:4233. PubMed
  173. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  174. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  175. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  176. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  177. Siew JJ, et al. 2019. Nat Commun. 10:3473. PubMed
  178. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  179. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  180. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  181. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  182. Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed
  183. Qiu F, et al. 2022. J Cancer. 13:2893. PubMed
  184. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  185. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  186. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  187. Liang P, et al. 2022. Mol Biomed. 3:14. PubMed
  188. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  189. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  190. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  191. Periasamy S, et al. 2011. J Leukoc Biol. 90:493. PubMed
  192. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  193. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  194. Luo W, et al. 2019. Mol Med Rep. 20:1007. PubMed
  195. Mayers S, et al. 2019. BMC Biotechnol. 19:21. PubMed
  196. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  197. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  198. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  199. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  200. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  201. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  202. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  203. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  204. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  205. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  206. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  207. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  208. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  209. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  210. Zong Z, et al. 2019. Front Immunol. 10:1643. PubMed
  211. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  212. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  213. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  214. Gao H, et al. 2021. Cells. 10:. PubMed
  215. Saitoh BY, et al. 2021. Brain Behav Immun. 95:362. PubMed
  216. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  217. Ohgomori T, et al. 2020. Neuropharmacology. 176:108227. PubMed
  218. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  219. Köchl R, et al. 2020. Elife. 9:00. PubMed
  220. Yuan F, et al. 2022. Front Immunol. 13:798583. PubMed
  221. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  222. Wu H, et al. 2022. Biomolecules. 12:. PubMed
  223. Lin D, et al. 2015. Proc Natl Acad Sci U S A. 112: 11324-11329. PubMed
  224. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  225. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  226. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  227. Perez–Zsolt D, et al. 2019. Front Immunol. 0.989583333. PubMed
  228. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  229. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  230. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  231. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  232. Koivisto CS, et al. 2020. Neoplasia. 1.252777778. PubMed
  233. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  234. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  235. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  236. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  237. Dong S, et al. 2021. Nature. 591:117. PubMed
  238. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  239. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  240. Yadav P, et al. 2021. J Immunol. 206:2888. PubMed
  241. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  242. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  243. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  244. Tan A, et al. 2012. Mol Pharmacol. 9:2710. PubMed
  245. Cappello P, et al. 2013. Gastroenterology. 144:1098. PubMed
  246. Meraz I, et al. 2014. PLoS One. 9:94703. PubMed
  247. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  248. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  249. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  250. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  251. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  252. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  253. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  254. Wang F, et al. 2018. Carcinogenesis. 39:889. PubMed
  255. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  256. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  257. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  258. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  259. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  260. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  261. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  262. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  263. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  264. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  265. Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed
  266. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  267. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  268. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  269. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  270. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  271. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  272. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  273. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  274. Cho K, et al. 2021. iScience. 24:103117. PubMed
  275. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  276. Bakker W, et al. 2021. Int J Mol Sci. 22:. PubMed
  277. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  278. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  279. Sobecki M, et al. 2021. Nat Commun. 12:4700. PubMed
  280. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  281. Miller S, et al. 2016. Acta Biochim Biophys Sin. 48: 334-341. PubMed
  282. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  283. Nishida J, et al. 2022. STAR Protoc. 3:101306. PubMed
  284. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  285. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  286. Li Y, et al. 2022. Front Cardiovasc Med. 9:830781. PubMed
  287. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  288. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  289. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  290. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  291. Chen X, et al. 2016. PLoS One. 11:e0168861. PubMed
  292. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  293. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  294. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  295. Simões FC, et al. 2020. Nat Commun. 0.875. PubMed
  296. Ku AT et al. 2017. eLife. 6 pii: e23242. PubMed
  297. Dong L, et al. 2022. Cells. 11:. PubMed
  298. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  299. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  300. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  301. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  302. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  303. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  304. Liu P, et al. 2022. iScience. 25:103867. PubMed
  305. Vasudevan SO, et al. 2022. Cell Rep. 39:110755. PubMed
  306. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  307. Niemi JP, et al. 2020. Methods Mol Biol. 2143:207. PubMed
  308. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  309. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  310. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  311. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  312. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  313. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  314. Jäger M, et al. 2018. Antioxid Redox Signal. 30. PubMed
  315. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  316. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  317. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  318. Chen S, et al. 2020. Allergy Asthma Immunol Res. 0.922222222. PubMed
  319. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  320. Chen Y, et al. 2022. Life Sci. 306:120826. PubMed
  321. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  322. Chen F, et al. 2016. J Immunol. 196: 4390 - 4399. PubMed
  323. Zhuo Y, et al. 2018. Oncol Rep. 40:2147. PubMed
  324. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  325. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  326. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  327. Yamamuro T, et al. 2020. Nat Commun. 3.340277778. PubMed
  328. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  329. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  330. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  331. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  332. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  333. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  334. Ostapoff K, et al. 2013. Mol Cancer Ther. 12:1190. PubMed
  335. Macagno M, et al. 2014. J Immunol. 192:5434. PubMed
  336. Chou H, et al. 2015. Proc Natl Acad Sci U S A. 112:2175. PubMed
  337. Quan S, et al. 2015. J Immunol. 194:4175. PubMed
  338. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  339. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  340. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  341. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  342. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  343. Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed
  344. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  345. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  346. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  347. Zhang GL, et al. 2020. Matrix Biol. 93:25. PubMed
  348. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  349. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  350. Mihalik NE, et al. 2021. AAPS PharmSciTech. 22:191. PubMed
  351. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  352. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  353. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  354. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  355. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  356. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  357. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  358. Kitamura K, et al. 2019. Int J Cardiol Heart Vasc. 23:100344. PubMed
  359. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  360. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  361. Alter C et al. 2019. Am J Physiol Heart Circ Physiol. 317(1):H190-H200 . PubMed
  362. Spolski R et al. 2019. Elife. 8 pii: e45501. PubMed
  363. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  364. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  365. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  366. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  367. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  368. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  369. Tang S, et al. 2022. Virol J. 19:32. PubMed
  370. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  371. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  372. Tähtinen S, et al. 2022. Nat Immunol. 23:532. PubMed
  373. Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed
  374. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  375. Fox D, et al. 2020. Nat Commun. 0.986111111. PubMed
  376. Deng M, et al. 2019. J Exp Med. 216:2838. PubMed
  377. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  378. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  379. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
  380. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  381. Chen J, et al. 2021. Oncol Lett. 21:409. PubMed
  382. Liu SS, et al. 2021. Immunity. :. PubMed
  383. Zhou JH, et al. 2020. Onco Targets Ther. 7.278472222. PubMed
  384. Sitapara RA, et al. 2020. Mol Med. 26:63. PubMed
  385. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  386. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  387. Wang X, et al. 2022. Elife. 11:. PubMed
  388. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  389. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  390. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  391. Zhong B, et al. 2013. Sci Signal. 6:35. PubMed
  392. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  393. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  394. Calvente CJ, et al. 2019. J Clin Invest. 130:4091. PubMed
  395. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  396. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  397. Uehara M, et al. 2019. Sci Rep. 9:6535. PubMed
  398. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  399. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  400. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  401. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  402. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  403. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  404. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  405. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  406. Palma A, et al. 2022. Front Cell Dev Biol. 10:841548. PubMed
  407. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  408. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  409. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  410. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  411. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  412. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  413. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  414. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  415. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  416. Xue Y, et al. 2020. Sci Rep. 10:22265. PubMed
  417. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  418. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  419. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  420. Wang S, et al. 2022. Blood. 140:171. PubMed
  421. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  422. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  423. Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
  424. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  425. Koronyo Y, et al. 2015. Brain. 138: 2399-2422. PubMed
  426. Zhao Y, et al. 2013. J Leukoc Biol. 94:1103. PubMed
  427. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  428. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  429. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
RRID
AB_312788 (BioLegend Cat. No. 101205)
AB_312789 (BioLegend Cat. No. 101206)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS B550™ anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account